BioCryst Pharmaceuticals, Inc. (BCRX) Stock News & Chart

(BCRX)

BioCryst Pharmaceuticals, Inc.

Stock chart and latest news for BioCryst Pharmaceuticals, Inc., tracked under Pharmaceuticals, Biotechnology & Life Sciences in the Health Care sector.

Chart powered byTradingView— professional charts for every trader.Try it free →

BioCryst Pharmaceuticals, Inc. News

PRO

Stock Traders Daily

BioCryst (BCRX) Chief R&D Officer receives large stock option and RSU inducement grants

Apr 7, 2026 Intellectia AI

BCRX Should I Buy

Apr 14, 2026 MSN

BioCryst stock jumps after hours on big pharma suitor buzz — retail sentiment hits 2026 peak

Mar 24, 2026 Stock Titan

12 new BioCryst hires receive stock awards tied to 157,300 shares

Apr 3, 2026 Intellectia AI

BCRX.O Forecast — Price Prediction for 2026. Should I Buy BCRX.O?

Apr 13, 2026 Yahoo Finance

Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition

Feb 23, 2026 Yahoo Finance

BioCryst (BCRX) Soars 13% on Acquisition Buzz

Mar 16, 2026

BioCryst Pharmaceuticals, Inc. News

Precision Trading with Biocryst Pharmaceuticals Inc. (BCRX) Risk Zones

BioCryst Pharmaceuticals, Inc. (BCRX) A Good Stock To Buy Now?

BCRX Stock Price, Quote & Chart | BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX)

BCRX.O Technical Analysis & Stock Price Forecast

BioCryst (BCRX) rallies 7.10% on acquisition buzz